PEN
Price
$263.69
Change
+$1.38 (+0.53%)
Updated
Jan 17 closing price
Capitalization
8.64B
38 days until earnings call
SNN
Price
$25.29
Change
+$0.24 (+0.96%)
Updated
Jan 17 closing price
Capitalization
10.95B
38 days until earnings call
Ad is loading...

PEN vs SNN

Header iconPEN vs SNN Comparison
Open Charts PEN vs SNNBanner chart's image
Penumbra
Price$263.69
Change+$1.38 (+0.53%)
Volume$433.78K
Capitalization8.64B
Smith & Nephew
Price$25.29
Change+$0.24 (+0.96%)
Volume$2.09M
Capitalization10.95B
PEN vs SNN Comparison Chart
Loading...
PEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PEN vs. SNN commentary
Jan 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PEN is a Hold and SNN is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 18, 2025
Stock price -- (PEN: $263.69 vs. SNN: $25.29)
Brand notoriety: PEN and SNN are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: PEN: 121% vs. SNN: 231%
Market capitalization -- PEN: $8.64B vs. SNN: $10.95B
PEN [@Medical Specialties] is valued at $8.64B. SNN’s [@Medical Specialties] market capitalization is $10.95B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PEN’s FA Score shows that 0 FA rating(s) are green whileSNN’s FA Score has 1 green FA rating(s).

  • PEN’s FA Score: 0 green, 5 red.
  • SNN’s FA Score: 1 green, 4 red.
According to our system of comparison, PEN is a better buy in the long-term than SNN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PEN’s TA Score shows that 5 TA indicator(s) are bullish while SNN’s TA Score has 4 bullish TA indicator(s).

  • PEN’s TA Score: 5 bullish, 3 bearish.
  • SNN’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, PEN is a better buy in the short-term than SNN.

Price Growth

PEN (@Medical Specialties) experienced а +5.22% price change this week, while SNN (@Medical Specialties) price change was +5.59% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.97%. For the same industry, the average monthly price growth was +5.53%, and the average quarterly price growth was +1.10%.

Reported Earning Dates

PEN is expected to report earnings on May 13, 2025.

SNN is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Medical Specialties (+0.97% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SNN($10.9B) has a higher market cap than PEN($8.64B). PEN has higher P/E ratio than SNN: PEN (93.70) vs SNN (40.76). PEN YTD gains are higher at: 11.037 vs. SNN (2.889). SNN has higher annual earnings (EBITDA): 956M vs. PEN (109M). SNN (302M) and PEN (289M) have equal amount of cash in the bank . PEN has less debt than SNN: PEN (234M) vs SNN (3.08B). SNN has higher revenues than PEN: SNN (5.55B) vs PEN (1.06B).
PENSNNPEN / SNN
Capitalization8.64B10.9B79%
EBITDA109M956M11%
Gain YTD11.0372.889382%
P/E Ratio93.7040.76230%
Revenue1.06B5.55B19%
Total Cash289M302M96%
Total Debt234M3.08B8%
FUNDAMENTALS RATINGS
PEN vs SNN: Fundamental Ratings
PEN
SNN
OUTLOOK RATING
1..100
189
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
5
Undervalued
PROFIT vs RISK RATING
1..100
53100
SMR RATING
1..100
8795
PRICE GROWTH RATING
1..100
4075
P/E GROWTH RATING
1..100
3491
SEASONALITY SCORE
1..100
95n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SNN's Valuation (5) in the Medical Specialties industry is significantly better than the same rating for PEN (97). This means that SNN’s stock grew significantly faster than PEN’s over the last 12 months.

PEN's Profit vs Risk Rating (53) in the Medical Specialties industry is somewhat better than the same rating for SNN (100). This means that PEN’s stock grew somewhat faster than SNN’s over the last 12 months.

PEN's SMR Rating (87) in the Medical Specialties industry is in the same range as SNN (95). This means that PEN’s stock grew similarly to SNN’s over the last 12 months.

PEN's Price Growth Rating (40) in the Medical Specialties industry is somewhat better than the same rating for SNN (75). This means that PEN’s stock grew somewhat faster than SNN’s over the last 12 months.

PEN's P/E Growth Rating (34) in the Medical Specialties industry is somewhat better than the same rating for SNN (91). This means that PEN’s stock grew somewhat faster than SNN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PENSNN
RSI
ODDS (%)
N/A
Bullish Trend 11 days ago
51%
Stochastic
ODDS (%)
Bearish Trend 11 days ago
73%
Bullish Trend 11 days ago
61%
Momentum
ODDS (%)
Bullish Trend 11 days ago
77%
N/A
MACD
ODDS (%)
Bullish Trend 11 days ago
90%
Bullish Trend 11 days ago
46%
TrendWeek
ODDS (%)
Bullish Trend 11 days ago
75%
Bearish Trend 11 days ago
63%
TrendMonth
ODDS (%)
Bullish Trend 11 days ago
73%
Bearish Trend 11 days ago
66%
Advances
ODDS (%)
Bullish Trend 11 days ago
82%
Bullish Trend 13 days ago
54%
Declines
ODDS (%)
Bearish Trend 19 days ago
71%
Bearish Trend 11 days ago
62%
BollingerBands
ODDS (%)
Bearish Trend 11 days ago
55%
N/A
Aroon
ODDS (%)
Bullish Trend 11 days ago
72%
Bearish Trend 11 days ago
61%
View a ticker or compare two or three
Ad is loading...
PEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SEPZ38.760.30
+0.79%
TrueShares Structured Outcome Sep ETF
SGLC33.590.23
+0.69%
SGI U.S. Large Cap Core ETF
GDX36.750.13
+0.36%
VanEck Gold Miners ETF
GFEB37.700.09
+0.23%
FT Vest U.S. Eq Mod Buffr ETF - Feb
BSJQ23.45N/A
N/A
Invesco BulletShares 2026 HY Corp Bd ETF

SNN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNN has been loosely correlated with TFX. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if SNN jumps, then TFX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNN
1D Price
Change %
SNN100%
+0.96%
TFX - SNN
55%
Loosely correlated
-0.10%
IDXX - SNN
43%
Loosely correlated
-2.18%
ZBH - SNN
37%
Loosely correlated
+0.57%
SONVY - SNN
37%
Loosely correlated
-0.72%
EW - SNN
36%
Loosely correlated
-0.11%
More